Silymarin — Hermetica Encyclopedia
Named Bioactive Compounds · Compound

Silymarin

Provisional Strong Scoreflavonolignan

Hermetica Superfood Encyclopedia

Evidence review status: unreviewed

Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.

Review flags: AWAITING_SEMANTIC_VALIDATION

Provisional Summary

Silymarin is a flavonolignan complex from milk thistle containing silybin, silydianin, and silychristin that protects liver cells through antioxidant and anti-inflammatory mechanisms. Clinical studies demonstrate its effectiveness in reducing liver enzymes and improving outcomes in nonalcoholic fatty liver disease and cirrhosis.

Screened PMID Records
Reported Benefits
Pending
Synergy Review
At a Glance
CategoryNamed Bioactive Compounds
GroupCompound
Public Score StatusProvisional Strong
Primary Keywordsilymarin benefits
Silymarin — botanical
Silymarin — botanical close-up

Origin & History

Silymarin — origin
Natural habitat

Silymarin is a standardized extract derived from the seeds of Silybum marianum (milk thistle), a plant native to the Mediterranean region. The extraction process typically yields a mixture of flavonolignans, with standardized extracts commonly containing 70-80% of the active flavonoid compounds.

The research notes that silymarin is commonly used by patients to treat chronic liver disease, though specific traditional medicine systems and historical timeframes are not detailed in the provided studies. Milk thistle has Mediterranean origins.Traditional Medicine

Research Narrative (Provisional)

Multiple randomized controlled trials have evaluated silymarin's efficacy, including a meta-analysis of 8 RCTs (n=587) for NAFLD, a Phase II trial (NCT00680407) testing 420-700mg doses in NASH, and a landmark survival study in 170 cirrhosis patients. Two separate RCTs in breast cancer patients demonstrated protection against chemotherapy-induced hepatotoxicity, while a trial in hepatitis C patients found no antiviral benefit despite good safety.

Preparation & Dosage

Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.

Nutritional Profile

Silymarin is a polyphenolic flavonolignan complex extracted primarily from milk thistle (Silybum marianum) seeds, not a food ingredient with conventional macronutrient/micronutrient profile. Bioactive composition: Silymarin complex typically contains 70-80% total flavonolignans by standardized extract weight. Primary components include silybin A and silybin B (silybin/silibinin being the most biologically active, comprising approximately 50-60% of the silymarin complex), isosilybin A and isosilybin B (~5% combined), silychristin (~20% of complex), silydianin (~10% of complex), and taxifolin (a flavonoid precursor, ~3%). Standardized milk thistle seed extracts typically contain 70-80mg silymarin per 100mg extract. Commercial supplements commonly deliver 140-800mg silymarin per daily dose. Macronutrients: Negligible in supplemental form; as a seed-derived compound, raw milk thistle seeds contain approximately 25% protein, 20-25% fixed oils (primarily linoleic acid), and 30-40% carbohydrates, but these are absent in purified silymarin extracts. Bioavailability: Poor oral bioavailability is a key limitation — conventional silymarin has approximately 23-47% absorption with extensive first-pass metabolism. Aqueous solubility is low (~0.04 mg/mL). Phosphatidylcholine complexes (siliphos/silybin-phosphatidylcholine) improve bioavailability by 4-10 fold. Nanoparticle and liposomal formulations further enhance absorption. Peak plasma concentration (Cmax) reached at approximately 1-4 hours post-ingestion. Half-life approximately 6 hours. Primarily excreted via bile (80%) with enterohepatic recirculation noted. No significant vitamin, mineral, or fiber content in purified silymarin extracts.

Reported Mechanism (Provisional)

Mechanism of Action

Silymarin's primary component silybin stabilizes hepatocyte membranes and inhibits lipid peroxidation through free radical scavenging. It modulates nuclear factor kappa B (NF-κB) signaling to reduce inflammatory cytokine production and activates antioxidant enzymes including glutathione peroxidase. The compound also inhibits stellate cell activation, reducing collagen synthesis and liver fibrosis progression.

Clinical Narrative (Provisional)

A meta-analysis of 587 patients with nonalcoholic fatty liver disease showed silymarin significantly reduced AST and ALT liver enzymes compared to placebo. In NASH patients, 22.4% showed liver fibrosis improvement versus 6.0% with placebo in randomized controlled trials. Long-term cirrhosis studies demonstrate improved 4-year survival rates of 58% versus 39% with placebo. Most studies used doses between 140-420mg daily of standardized silymarin extract.

Also Known As

Silybum marianum extractMilk thistle extractMarian thistleMary thistleHoly thistleLady's thistleSilibinin complex

Explore the Full Encyclopedia

Browse evidence-gated ingredient records with transparent editorial and citation standards.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
From the Hermetica Research Desk

Research updates — and 25% off your first order

Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.

Educational content only — not medical advice.